US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

iShares Biotechnology ETF

210.53

-0.5100-0.24%

Post-market: 210.530.00000.00%19:40 EDT

Volume:1.94M

Turnover:410.08M

Market Cap:10.68B

PE:33.35

High:212.62

Open:210.89

Low:209.84

Close:211.04

52wk High:217.12

52wk Low:144.65

Shares:50.75M

Float Shares:50.75M

Volume Ratio:1.36

T/O Rate:3.82%

Dividend:0.34

Dividend Rate:0.16%

EPS(TTM):6.31

EPS(LYR):35.34

ROE:24.54%

ROA:0.10%

PB:1.31

PE(LYR):5.96

Loading ...

Overview Company News Filings

Sino Biopharmaceutical Jumps Nearly 4% as Subsidiary Strikes Strategic Biosimilar Deal with STADA, Securing Up to EUR53 Million in Upfront Payment

Teva announces FDA approval of Degevma as a biosimilar to Xgeva

Teva Wins US FDA Approval for Xgeva Biosimilar Degevma

Sector Update: Healthcare

MT Newswires Live

Ocular Therapeutix Tumbles on Rival Kodiak's Trial Win, Analyst Calls Selloff Overdone

Exchange-Traded Funds Lower as US Equities Decline After Midday

MT Newswires Live

Analysts Offer Insights on Healthcare Companies: Regeneron (REGN) and Kodiak Sciences (KOD)

Mirum's Liver Infection Drug Lowers Virus Levels in Late-Stage Study

Inside the Eye-Drug Breakthrough That Sent Kodiak Sciences up 156%

Amgen Stock Forecast: Sjögren’s Trial Success Tests AMGN’s Pipeline Outlook

US Drugmakers Turn to China for Licensing Deals

Exchange-Traded Funds, Equity Futures Lower Pre-Bell Monday as Oil Prices Rise

MT Newswires Live

Sector Update: Healthcare

MT Newswires Live

Xilio Therapeutics Names Yariv Houvras Chief Medical Officer

Kodiak Sciences Rises After Eye-Disease Drugs Meet Trial Goals

Zymeworks sees FY26 revenue $278M-$292M, consensus $304.04M

Sino Biopharmaceutical Stock Slides 1.3% in Hong Kong, Underperforms Competitors

EBR Systems advances FDA approval process for new WiSE manufacturing site

Regeneron (REGN) Receives a Hold from Bernstein

Analysts Are Bullish on Top Healthcare Stocks: Agilent (A), Regeneron (REGN)

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg1.tigeractivity.com/stock/IBB/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IBB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBB\",,,,,undefined,":{"symbol":"IBB","market":"US","secType":"STK","nameCN":"iShares Biotechnology ETF","latestPrice":210.53,"timestamp":1790798400000,"preClose":211.04,"halted":0,"volume":1939806,"hourTrading":{"tag":"盘后","latestPrice":210.53,"preClose":210.53,"latestTime":"19:40 EDT","volume":10410,"amount":2191616.46,"timestamp":1790811644228,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.00241660348749048,"floatShares":50750000,"shares":50750000,"eps":6.311863,"marketStatus":"Not Yet Opened","change":-0.51,"latestTime":"09-30 16:00:00 EDT","open":210.89,"high":212.62,"low":209.84,"amount":410084027.89596003,"amplitude":0.013173,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":6.311863,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1790841600000},"marketStatusCode":0,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":211.04,"sharesOutstanding":49450000,"nav":211.023541,"aum":11226452381.2,"dividendRate":0.001601,"bidAskSpread":0.000363,"preHourTrading":{"tag":"盘前","latestPrice":211.2882,"preClose":211.04,"latestTime":"09:24 EDT","volume":566,"amount":119591.50972,"timestamp":1790774676281,"change":0.2482,"changeRate":0.001176,"amplitude":0.008438},"postHourTrading":{"tag":"盘后","latestPrice":210.53,"preClose":210.53,"latestTime":"19:40 EDT","volume":10410,"amount":2191616.46,"timestamp":1790811644228,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.357064,"impliedVol":0.2393,"impliedVolPercentile":0.58},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBB\",,,,,undefined,":{"symbol":"IBB","floatShares":50750000,"roa":"0.10%","roe":"24.54%","lyrEps":35.344796,"volumeRatio":1.357064,"shares":50750000,"dividePrice":0.3371,"high":212.62,"amplitude":0.013173,"preClose":211.04,"low":209.84,"week52Low":144.65,"pbRate":"1.31","psRate":"257.06","week52High":217.12,"institutionHeld":0,"latestPrice":210.53,"eps":6.311863,"divideRate":0.001601,"volume":1939806,"delay":0,"ttmEps":6.311863,"open":210.89,"prevYearClose":168.77,"prevWeekClose":209.77,"prevMonthClose":209.05,"prevQuarterClose":190.19,"fiveDayClose":206.6,"twentyDayClose":210.82,"sixtyDayClose":198.23},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IBB\",params:#limit:5,,,undefined,":[{"date":"2026-09-15","symbol":"IBB","amount":0.011194,"announcedDate":"2026-09-14","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-09-15","defaultRemindTime":1789479000000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-18","payableDate":"2026-09-15","currency":"USD","dateTimestamp":1789444800000,"payDate":"2026-09-18"},{"date":"2026-06-15","symbol":"IBB","amount":0.023774,"announcedDate":"2026-06-12","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-15","defaultRemindTime":1781530200000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-18","payableDate":"2026-06-15","currency":"USD","dateTimestamp":1781496000000,"payDate":"2026-06-18"},{"date":"2026-03-17","symbol":"IBB","amount":0.121818,"announcedDate":"2026-03-16","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-17","defaultRemindTime":1773754200000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-20","payableDate":"2026-03-17","currency":"USD","dateTimestamp":1773720000000,"payDate":"2026-03-20"},{"date":"2025-12-16","symbol":"IBB","amount":0.183099,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-19","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-19"},{"date":"2025-09-16","symbol":"IBB","amount":0.082843,"announcedDate":"2025-09-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-16","defaultRemindTime":1758029400000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-19","payableDate":"2025-09-16","currency":"USD","dateTimestamp":1757995200000,"payDate":"2025-09-19"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IBB\",market:\"US\",,,undefined,":[{"executeDate":"2016-12-22","recordDate":"2016-12-27","paymentDate":"2016-12-29","value":0.091903,"currency":"USD"},{"executeDate":"2017-03-24","recordDate":"2017-03-28","paymentDate":"2017-03-30","value":0.29898,"currency":"USD"},{"executeDate":"2017-06-27","recordDate":"2017-06-29","paymentDate":"2017-06-30","value":0.176803,"currency":"USD"},{"executeDate":"2017-09-26","recordDate":"2017-09-27","paymentDate":"2017-09-29","value":0.118654,"currency":"USD"},{"executeDate":"2018-06-26","recordDate":"2018-06-27","paymentDate":"2018-07-02","value":0.15606,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IBB\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IBB\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1188705505","title":"Sino Biopharmaceutical Jumps Nearly 4% as Subsidiary Strikes Strategic Biosimilar Deal with STADA, Securing Up to EUR53 Million in Upfront Payment","url":"https://stock-news.laohu8.com/highlight/detail?id=1188705505","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1188705505?lang=en_us&edition=fundamental","pubTime":"2026-09-29 10:03","pubTimestamp":1790647387,"startTime":"0","endTime":"0","summary":"Shares of Sino Biopharmaceutical (01177) climbed nearly 4%, rising 3.64% to HK$5.695 as of press time, with turnover reaching HK$89.7588 million.On the news front, Sino Biopharmaceutical announced...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","KCAI","LU2272731865.HKD","XPH","01177","MEURmain","EURmain","IE00BZ08YS42.EUR","IE00BZ08YT58.USD","LU2322448957.HKD","BK4588","NBIE","LU2272731600.USD","BK4585","IBB","LU1992135472.HKD","IE00BZ08YR35.GBP","LU2473716301.USD","IE00B5TLWC47.USD","FXE","VXUS","LU2322448791.USD","BK1515","HK0000165453.HKD","LU2272731782.SGD","EUO","BK1589","BK1521","PPH","LU1992135399.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671125702","title":"Teva announces FDA approval of Degevma as a biosimilar to Xgeva","url":"https://stock-news.laohu8.com/highlight/detail?id=2671125702","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671125702?lang=en_us&edition=fundamental","pubTime":"2026-09-29 04:05","pubTimestamp":1790625914,"startTime":"0","endTime":"0","summary":"Teva (TEVA) Pharmaceutical Industries announced that the FDA has approved Degevma as a biosimilar to Xgeva. Degevma is indicated for the prevention...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/teva-announces-fda-approval-of-degevma-as-a-biosimilar-to-xgeva-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/teva-announces-fda-approval-of-degevma-as-a-biosimilar-to-xgeva-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["FRTY","LU2324357040.USD","BMED","MRNX","GNMX","BK4584","LFSC","IEIH","XLVX","BK4559","TEVA","RSPH","BK4596","MEDI","MRNY","BK4557","BK4588","BBP","GDOC","BK4585","IDNA","PINK","BK4007","SYNB","NVIB","LU1983299246.USD","LABU","TECB","BK4566","PSCH","IYH","TBXU","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671257160","title":"Teva Wins US FDA Approval for Xgeva Biosimilar Degevma","url":"https://stock-news.laohu8.com/highlight/detail?id=2671257160","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671257160?lang=en_us&edition=fundamental","pubTime":"2026-09-29 04:00","pubTimestamp":1790625646,"startTime":"0","endTime":"0","summary":"Teva wins US FDA approval for Xgeva biosimilar DEGEVMATeva won FDA clearance for DEGEVMA (denosumab-adet), a biosimilar to Amgen’s Xgeva.Label covers Xgeva’s full uses, including prevention of bone co","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nNDL4w4Bbr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999001440.SGD","BK4533","IE00B4R5TH58.HKD","IBB","IE00B64PRP62.GBP","LU1061106388.HKD","BK4566","LU1571399168.USD","BK4599","LU0320765992.SGD","IE00BN0W2V16.EUR","BCDF","NDAQ","IE00BN0W2T93.GBP","TBXU","IE00BKPKM429.USD","LU0889565916.HKD","LU2112291526.USD","IE0002141913.USD","PBE","BK4534","IE00BJT1NW94.SGD","LU2468319806.SGD","BK4585","IE0009355771.USD","LU1983299246.USD","BK4139","IE00BQXX3F31.USD","LU1057294990.SGD","SG9999014021.USD","IE00BQXX3D17.EUR","AMGN","SG9999014013.SGD","PJP","IE00BN0W2W23.USD","LU0122379950.USD","BIB","IE00BFTCPJ56.SGD","LU0314104364.USD","LU2210149790.SGD","BK4112","LU0058720904.USD","BBH","BK4588","LU2242646821.SGD","SG9999014039.USD","LU0289739699.SGD","LU2089984988.USD","IBBQ","LU2242652126.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671257344","title":"Sector Update: Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2671257344","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671257344?lang=en_us&edition=fundamental","pubTime":"2026-09-29 03:32","pubTimestamp":1790623963,"startTime":"0","endTime":"0","summary":"Healthcare stocks rose late Monday afternoon with the NYSE Healthcare Index and the State Street Health Care Select Sector SPDR ETF  each adding 0.3%.The iShares Biotechnology ETF  rose 0.8%.In corporate news, Eli Lilly  plans to pursue larger pharmaceutical deals as it looks to expand into new therapeutic areas, Bloomberg reported, citing an interview with CEO David Ricks on the sidelines of a diabetes conference in Milan. Ricks cited infectious disease, women's health, and psychiatric conditions as possible areas of opportunity in a broadening search for pharmaceutical deals, the report said. Lilly shares were up 0.4%.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LLII","LU1989771016.USD","LU1868837300.USD","SG9999018857.SGD","LU0823434583.USD","LU2468319806.SGD","BK4585","LU1145028129.USD","IE0001KFT4U8.USD","BK4588","IE00B7KXQ091.USD","ELIS","LU2108987350.USD","LU0354030511.USD","IE00BJJMRZ35.SGD","LU0823434740.USD","LU1868836914.USD","SG9999014914.USD","GDOC","LU0061475181.USD","LU2471134879.HKD","LU0889565916.HKD","LU2361044865.SGD","LU2746668974.SGD","IBB","LU0203202063.USD","LU1023059063.AUD","SG9999013999.USD","LU0320765059.SGD","LU0466842654.USD","LU1720051017.SGD","OZEM","LU2089284900.SGD","LU2491050154.USD","SGXZ51526630.SGD","SG9999018865.SGD","LU0079474960.USD","IE0002141913.USD","JDOC","LU1061106388.HKD","IXJ","IE00BJJMRX11.SGD","LU0225283273.USD","LU2111349929.HKD","LU2168563687.JPY","LU1712237335.SGD","LU1814569148.SGD","LU2456880835.USD","LU2106854487.HKD","PPH","LU1366192091.USD","LU2023250504.SGD","BK4599","VHT","LU0471298777.SGD","AGNG","LU2237443622.USD","LU0109394709.USD","LU2168564222.USD","LU2168564495.EUR","LU2462591350.SGD","IE0009355771.USD","LU0094547139.USD","IE00BKDWB100.SGD","SG9999017495.SGD","FHLC","LU2471134796.USD","IE0005OL40V9.USD","LU2552382215.SGD","LU1868837136.USD","MHIP","LU0683600562.USD","LABU","LU1974910355.USD","LU0096364046.USD","CURE","SGXZ57979304.SGD","LU0786609619.USD","IE00BFSS8Q28.SGD","BK4581","LU0787776722.HKD","LU1868836591.USD","LU0058720904.USD","LLYZ","LU0174119429.USD","LU2168564149.EUR","IE00BJJMRY28.SGD","LU2265009873.SGD","LU2471134952.CNY","XLV","LU0133085943.USD","LU2360106947.USD","LU0882574055.USD","HRTS","TMED","IE0004445015.USD","LU0689472784.USD","IE0004445239.USD","LU0256863811.USD","LU0672654240.SGD","SG9999014906.USD","SGXZ81514606.USD","LU0820561818.USD","LU2324357040.USD","LU2063271972.USD","LU0823416689.USD","LU0353189680.USD","IE00B1XK9C88.USD","RXL","PJP","SG9999001176.USD","LU0345770308.USD","SG9999014880.SGD","LU0266013472.USD","LU0456855351.SGD","LU2168564065.EUR","LU2750360641.GBP","LU1551013342.USD","GB00BDT5M118.USD","LU2461242641.AUD","LU2471134523.USD","LU0203201768.USD","LU1069344957.HKD","LU2756315664.SGD","LU1323610961.USD","LU0882574139.USD","IE00BFSS7M15.SGD","LU0198837287.USD","LU0943347566.SGD","LU0471298694.HKD","LU0234572021.USD","LU2361044949.HKD","LU0006306889.USD","LU0353189763.USD","LU1868836757.USD","LU1232071149.USD","LU2089984988.USD","BK4534","LU1057294990.SGD","LU2491050071.SGD","LU2896262040.SGD","LU2023250330.USD","LU0964807845.USD","LU0320765992.SGD","LU2237443549.SGD","MEDX","LU1720051108.HKD","LU2746668461.USD","LU0354030438.USD","IE00BFTCPJ56.SGD","LU0708995401.HKD","XBI","LU2236285917.USD","LU0385154629.USD","LU0158827781.USD","IHE","LU1267930730.SGD","SG9999001176.SGD","LU0417517546.SGD","LU0106261372.USD","LU2417539215.USD","TRUH","ILDR","SGXZ99366536.SGD","LU0345770993.USD","LU0820562030.AUD","SG9999015986.USD","LU1623119135.USD","LU2491049909.HKD","IE00BK4W5M84.HKD","CANC","LU1551013425.SGD","LU0640476718.USD","LU2237443978.SGD","WDNA","IE00BJT1NW94.SGD","SGXZ31699556.SGD","LU1064131342.USD","LU0109391861.USD","LU2112291526.USD","LU2361045086.USD","LU2750360997.AUD","LU2462157665.USD","LU2211815571.USD","LU0114720955.EUR","IE00BWXC8680.SGD","SG9999015978.USD","LU0238689110.USD","SG9999014898.SGD","LU0256863902.USD","LU2213496289.HKD","LU2237443382.USD","IYH","LU0122379950.USD","LU1127390331.HKD","LU2028103732.USD","IE00B2B36J28.USD","LU2089283258.USD","FTXH","LU1093756168.USD","BK4533","LU2271345857.HKD","LU0316494557.USD","IE00B4JS1V06.HKD","LU2087625088.SGD","LU1548497426.USD","SG9999015945.SGD","LU0210536198.USD","LU1291159041.SGD","BK4516","LLY","IE00BK4W5L77.USD","LU0432979614.USD","BK4007","LU1691799644.USD","LU2023251221.USD","LU2602419157.SGD","IE00BN29S564.USD","MEDI","IE00BJLML261.HKD","LU0158827948.USD","LU1035775433.USD","LU0097036916.USD","LU1804176565.USD","LLYX","THNR","LU2237443895.HKD","IE00BKPKM429.USD","LU2756315318.SGD","LU2237443465.HKD","IE00B4R5TH58.HKD","LU2237438978.USD","LU2264538146.SGD","LU0289739699.SGD","LU1988902786.USD","LU1629891620.HKD","LU1983299246.USD","LU1093756325.SGD","SG9999015952.SGD","LU1979441026.SGD","IE00B1BXHZ80.USD","LU2552382058.USD","LU2552382132.HKD","LU2357305700.SGD","IE00B775H168.HKD","LU1280957306.USD","LU0323591593.USD","LU1917777945.USD","ELIL","LU0820561909.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671252933","title":"Ocular Therapeutix Tumbles on Rival Kodiak's Trial Win, Analyst Calls Selloff Overdone","url":"https://stock-news.laohu8.com/highlight/detail?id=2671252933","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671252933?lang=en_us&edition=fundamental","pubTime":"2026-09-29 02:37","pubTimestamp":1790620623,"startTime":"0","endTime":"0","summary":"BUZZ-Ocular Therapeutix tumbles on rival Kodiak's trial win, analyst calls selloff overdone** Shares of Ocular TherapeutixOCUL.Ofall 18.8% to $7.84 in afternoon trading** Kodiak Sciences'KOD.Oexperime","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nL4N45K1CH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0114720955.EUR","LU0058720904.USD","LU0823434583.USD","BBH","LU0109394709.USD","REGN","LU2362540622.SGD","LU2023250504.SGD","LU1974910355.USD","LU0823434740.USD","LU0823416689.USD","LU0889565916.HKD","KOD","LU2237438978.USD","OCUL","LU2362541513.USD","LU2362541273.HKD","BK4588","BK4007","IBB","BK4585","LU2106854487.HKD","BK4139","TBXU","IBBQ","LU0289739699.SGD","LU1917777945.USD","LU0053666078.USD","LU2468319806.SGD","LU0882574055.USD","LU0320765992.SGD","LU2089984988.USD","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671543832","title":"Exchange-Traded Funds Lower as US Equities Decline After Midday","url":"https://stock-news.laohu8.com/highlight/detail?id=2671543832","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671543832?lang=en_us&edition=fundamental","pubTime":"2026-09-29 01:26","pubTimestamp":1790616373,"startTime":"0","endTime":"0","summary":"Broad Market IndicatorsBroad-market exchange-traded funds IWM and IVV fell. Actively traded Invesco QQQ Trust (QQQ) shed 1%.US equity indexes fell in midday trading on Monday as oil prices and Treasur","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IWM","ESK","SHNY","BTCW","QMAR","IWMI","KGLD","SOXX","SPXU","HIBL","QQQ","SPYU","BK4581","SMAX","USSX","SLV","SCO","SETH","SOXL","DZZ","EETH","XLF","VIS","FGDL","XLK","DGZ","BK4550","CBOO","TECL","VDC","BTCI","CBTJ","ETH.USD.CC","BK4547","DFII","ZSL","RYLD","BFJL","SRTY","USG","DULL","SPYH","CBXO",".SPX","BITI","PSQ","IYE","VTWO","XBI","YGLD","ETH","ETCO","CBOJ","BK4561","BTCL","IAU","IBB","SGOL","BITU","SQQQ","UPRO","XLP","YSPY","VHT","SPYQ","TQQY","BAGY","BTC.USD.CC","CBXY","SH","NJUL","RWM","BRRR","IYW","BCCC","IGM","NOCT","UCO","RTH","DGP","UGL","CBOY","EZBC","ETQ","GLL","TQQQ","BITO","QID","SPXS","XLI","LABU","BK4588","SIVR","AGQ","BTC","UWM","CBXJ","GPIQ","QBF","IAUM","RSSL","BTCO","CBTA","QLD","SPYM","XAGUSD.FOREX","SDS","XLY","BTCZ","TZA","XRT","URTY","BAR","BITB","IYJ","TETH","BFAP","BK4504","CBTO","SPY","FBTC","TWM","GBTC","IAUI","XBTY","BTCC","FAZ","BTF","USO","AVUV","DMAX","ETHT","VB","ARKB","IVV","IBIT","SOXS","XLPD","BK4534","DEFI","NAPR","ETHD","BK4535","TNA","MNQmain","NDX","CBOA","BETE","BPI","GLDY","RETL","IWF","BTRN","AAAU","SPUU","CBTY","BK4585","BITX","HODL","MMAX","SSO","UNG","XLE","XSD","SBIT","IGLD","FAS","NJAN","IWN","QQQM","CBXA","BITY","XLV","OUNZ","GLD","GLDM","YBTC","IYH","QDEC","SPDN","QQQX","SPXL","MNRS","BK4570","XAUUSD.FOREX","BK4593","BGLD","XLPU","BETH","MAXI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671259773","title":"Analysts Offer Insights on Healthcare Companies: Regeneron (REGN) and Kodiak Sciences (KOD)","url":"https://stock-news.laohu8.com/highlight/detail?id=2671259773","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671259773?lang=en_us&edition=fundamental","pubTime":"2026-09-29 00:00","pubTimestamp":1790611227,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Regeneron (REGN) and Kodiak Sciences (KOD). Regeneron (REGN) Citi...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-regeneron-regn-and-kodiak-sciences-kod-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-regeneron-regn-and-kodiak-sciences-kod-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2106854487.HKD","IBB","LU0823416689.USD","LU0823434740.USD","BBH","LABU","XLV","LU1917777945.USD","KOD","LU2362541273.HKD","XBI","LU0114720955.EUR","HCSG","LU0109394709.USD","LU2089984988.USD","LU2362540622.SGD","LU0053666078.USD","LU2468319806.SGD","LU2362541513.USD","TBXU","BK4588","LU0058720904.USD","LU0289739699.SGD","LU0128526141.USD","IBBQ","LU2023250504.SGD","LU0889565916.HKD","LU0320765992.SGD","REGN","LU0029874061.USD","BK4581","BK4505","BK4137","BK4585","LU2237438978.USD","LU0823434583.USD","BK4139","LU1974910355.USD","LU0882574055.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670564812","title":"Mirum's Liver Infection Drug Lowers Virus Levels in Late-Stage Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2670564812","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670564812?lang=en_us&edition=fundamental","pubTime":"2026-09-28 23:23","pubTimestamp":1790609027,"startTime":"0","endTime":"0","summary":"UPDATE 1-Mirum's liver infection drug lowers virus levels in late-stage studySept 28 (Reuters)-Mirum PharmaceuticalsMIRM.Oon Monday said its experimental hepatitis drug reduced levels of the virus in ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nL4N45K14L:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BKVL7J92.USD","BK4139","TMED","LU2468319806.SGD","LU2087621335.USD","IE00BSNM7G36.USD","LU0234570918.USD","LU2089984988.USD","BK4585","LU0882574055.USD","LU1934455863.HKD","IBBQ","BK4532","IE00B3T34201.USD","LU1839511570.USD","LU0289739699.SGD","MEDI","LU0058720904.USD","LU0122379950.USD","BK4566","LU0889565916.HKD","LU2112291526.USD","BK4588","BMED","LU0965509101.SGD","LU1057294990.SGD","LU0320765992.SGD","LU1430594728.SGD","LU0859254822.USD","IBB","LU0965509283.SGD","LU1066051498.USD","LU1674673428.USD","LU2324357040.USD","LU2357627491.SGD","SG9999015986.USD","LU1585245621.USD","MIRM","LU1778281490.HKD","LU0861579265.USD","LU1066053197.SGD","LU1934455194.USD","IE0002270589.USD","SG9999015952.SGD","LU1023059063.AUD","GILD","IE00B19Z3581.USD","TBXU","BBH","BIB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670620256","title":"Inside the Eye-Drug Breakthrough That Sent Kodiak Sciences up 156%","url":"https://stock-news.laohu8.com/highlight/detail?id=2670620256","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670620256?lang=en_us&edition=fundamental","pubTime":"2026-09-28 23:11","pubTimestamp":1790608260,"startTime":"0","endTime":"0","summary":"Shares of Kodiak Sciences more than doubled Monday after two experimental eye drugs succeeded in a late-stage trial, positioning the biopharmaceutical company to get its first product to market.Kodiak","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KOD","LU0889565916.HKD","LU2468319806.SGD","REGN","BBH","LU2023250504.SGD","LU0320765992.SGD","LU2237438978.USD","BK4585","LU0823416689.USD","LU1974910355.USD","IBB","LU0289739699.SGD","IBBQ","TBXU","LU2362540622.SGD","LU2089984988.USD","LU0053666078.USD","LU0058720904.USD","LU2362541273.HKD","LU0823434583.USD","BK4505","OTLK","LU0109394709.USD","LU2362541513.USD","BK4588","LU0823434740.USD","LU1917777945.USD","LU2106854487.HKD","BK4139","LU0882574055.USD","LU0114720955.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670256598","title":"Amgen Stock Forecast: Sjögren’s Trial Success Tests AMGN’s Pipeline Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2670256598","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670256598?lang=en_us&edition=fundamental","pubTime":"2026-09-28 23:00","pubTimestamp":1790607600,"startTime":"0","endTime":"0","summary":"TradingKey - Amgen’s latest Sjögren’s trial success adds to its pipeline, while Repatha growth and MariTide trials shape the AMGN stock outlook for 2026.","market":"nz","thumbnail":"https://resource.tradingkey.com/uploads/20260928/AMGEN-b0736da492b74294b066d7d43a826369.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/uploads/20260928/AMGEN-b0736da492b74294b066d7d43a826369.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/analysis/stocks/us-stocks/262189733-stocks-amgen-stock-forecast-sjogrens-trial-maritide-2026-tradingkey","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0029864427.USD","LU1057294990.SGD","AZN","BK4588","AZNH","BK4581","LU2112291526.USD","IE00B4R5TH58.HKD","LU2237443622.USD","PJP","LU0109394709.USD","LU0128525929.USD","BIB","LU2089984988.USD","IE00BJT1NW94.SGD","LU0708994859.HKD","TBXU","BK4566","LU1829250122.USD","LU2237443978.SGD","LU0320765992.SGD","BK4533","IE0009355771.USD","LU1571399168.USD","LU2237443465.HKD","LU2237443895.HKD","LU0889565916.HKD","LU0432979614.USD","LU2242652126.USD","AMGN","IBB","IE0002141913.USD","LU0310800379.SGD","IE00BFTCPJ56.SGD","LU2456880835.USD","LU2468319806.SGD","BBH","BK4007","LU2237443382.USD","BK4534","LU0289739699.SGD","LU0122379950.USD","IE00B3T34201.USD","LU0058720904.USD","LU2236285917.USD","IBBQ","PBE","SG9999001440.SGD","IE00BJJMRZ35.SGD","LU2237443549.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670255552","title":"US Drugmakers Turn to China for Licensing Deals","url":"https://stock-news.laohu8.com/highlight/detail?id=2670255552","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670255552?lang=en_us&edition=fundamental","pubTime":"2026-09-28 22:31","pubTimestamp":1790605880,"startTime":"0","endTime":"0","summary":"FACTBOX-US drugmakers turn to China for licensing dealsSept 28 (Reuters)-MerckMRK.Non Monday agreed to payChinese biotechSciBrunch Therapeutics $400 million upfront for global rights to an experimenta","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nL4N45K0UD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0203201768.USD","SG9999014914.USD","IE00BBT3K403.USD","LU0203202063.USD","SG9999018857.SGD","IE00B19Z3581.USD","TBXU","LU1244550494.USD","LU0868494617.USD","LU0882574139.USD","LU1069344957.HKD","LU2357627491.SGD","LU0965509010.AUD","BK4550","ELIS","LU2023250330.USD","IE00BLSP4452.SGD","LU0965509101.SGD","LU0417517546.SGD","LU1941712348.USD","SG9999015358.SGD","IE0002141913.USD","LU1868837136.USD","LU1116320901.HKD","LU0868494708.USD","LU2168564222.USD","LU0211327993.USD","IBB","SGXZ51526630.SGD","LU2242646821.SGD","BK4592","LU1934455277.USD","LU1670711040.USD","LU1201861249.SGD","SG9999018865.SGD","LU2417539215.USD","LU0320765646.SGD","LU0466842654.USD","SG9999015341.SGD","LU0985320562.USD","LU2097828474.EUR","LU0256863811.USD","LU1093756168.USD","LU1066051811.HKD","LU1839511570.USD","LU0203347892.USD","LU0943347566.SGD","LU1670711123.USD","SG9999014575.USD","LU0174119429.USD","LU2125154778.USD","IE00BFSS8Q28.SGD","LU0070302665.USD","LU2461242641.AUD","LU2347655073.USD","SGXZ57979304.SGD","LU1831875114.USD","LU0795875169.SGD","IE00B4R5TH58.HKD","LU0128525929.USD","LU2552382215.SGD","LU2361045086.USD","LU2433249047.HKD","IE00B2B36J28.USD","SG9999001176.SGD","LU1116320737.USD","IE00BWXC8680.SGD","LU1670710661.SGD","LU0069063385.USD","BK4534","IE0004445239.USD","LU2471134952.CNY","LU2471134879.HKD","IE0009355771.USD","AGNG","IE000WAW04H5.SGD","LU1917777945.USD","LU2097828557.USD","LLII","LU1929549753.HKD","LU2125154935.USD","LU0320765992.SGD","LU0820562030.AUD","LU2089984988.USD","LU0211328371.USD","LU0689626769.HKD","LU1023059063.AUD","LU2750360641.GBP","LU2168564495.EUR","IE000M9KFDE8.USD","LU0661504455.SGD","SG9999017495.SGD","IE00B3PB1722.GBP","LU0502904849.HKD","LU1035775433.USD","LU0985481810.HKD","HK0000165453.HKD","LU2237443978.SGD","LU0289961442.SGD","LU0787776722.HKD","LU2168564065.EUR","LU1551013425.SGD","MEDX","IE00B42XCP33.USD","LU1934455194.USD","LU2106854487.HKD","IE00BK4W5L77.USD","LU1571399168.USD","HRTS","LU0463099449.HKD","LU1267930730.SGD","LLYX","OZEM","LU1585245621.USD","LU1127390331.HKD","LU1064131342.USD","LU2168563687.JPY","LU1883839398.USD","LU2237443465.HKD","LU0980610538.SGD","LU0306806265.USD","IE00B1XK9C88.USD","LU0471298694.HKD","LU1066051498.USD","LU2462591350.SGD","PPH","SG9999003800.SGD","LU0130517989.USD","LU2242644610.SGD","SG9999013999.USD","LU1066053197.SGD","LU2112291526.USD","LU1814569148.SGD","PFE","LU1969619763.USD","LU2468319806.SGD","LU0345770308.USD","LU1670628061.USD","LU0689472784.USD","IE00B7KXQ091.USD","LU0162691827.USD","SG9999015986.USD","LU0203345920.USD","LU1732800096.USD","SG9999014559.SGD","LU0225283273.USD","LU0823434740.USD","LU2324357040.USD","LU0124676726.USD","ELIL","SGXZ31699556.SGD","LU0708995401.HKD","LU2242652126.USD","LU1496350502.SGD","LU0256863902.USD","LU0244354667.USD","LU0964807845.USD","LU0823434583.USD","LU1720051108.HKD","LU0058720904.USD","BK4533","SG9999014906.USD","LU0354030438.USD","LU1323610961.USD","SGXZ99366536.SGD","LU0057025933.USD","LU1988902786.USD","LU0198837287.USD","LU1868837300.USD","LU1366192091.USD","LU1069347547.HKD","IE00B1BXHZ80.USD","BK4599","LU2360106947.USD","LU0477156953.USD","LU2462157665.USD","LU2237443622.USD","LU2211815571.USD","LU1623119135.USD","BK4559","LU1188198961.HKD","LU0353189763.USD","LU0823416689.USD","LU1979441026.SGD","LU2456880835.USD","IE00BGHQF631.EUR","SG9999014898.SGD","SG9999001440.SGD","IE00B775H168.HKD","LU2129689431.USD","BK4566","GB00BDT5M118.USD","LU0006306889.USD","LU0225771236.USD","IE00BJJMRX11.SGD","IE00BLSP4239.USD","IE0001KFT4U8.USD","LU0323591593.USD","LU1003077747.HKD","LU0882574055.USD","LU0306807586.USD","LU0320765059.SGD","LU2357305700.SGD","LU0683600562.USD","SG9999015978.USD","LU1551013342.USD","XLV","IE00BJLML261.HKD","LU0170899867.USD","BK4516","LU0820561818.USD","IE00BKDWB100.SGD","LU0234572021.USD","SG9999014880.SGD","LU0353189680.USD","LU1057294990.SGD","LU2347655156.SGD","LU1983299246.USD","LU2360032135.SGD","LU2750360997.AUD","IE00B4JS1V06.HKD","LU1093756325.SGD","LU2097828714.EUR","RXL","LU0949170772.SGD","LU2552382058.USD","LU0234570918.USD","BK4581","LU1061106388.HKD","LU1989772840.SGD","LU1670627923.USD","LU0225284248.USD","LU2271345857.HKD","LU0237698245.USD","LU1232071149.USD","LU0708994859.HKD","LU2168564149.EUR","BMY","SG9999002224.SGD","LU1868836757.USD","LU2023250843.SGD","LU2756315664.SGD","LU1236620834.HKD","LU1712237335.SGD","LU0511384066.AUD","LU1162221912.USD","SG9999014542.SGD","ABBV","LU1496350171.SGD","LU0321505439.SGD","LU0345770993.USD","SGXZ81514606.USD","GDOC","LU1548497426.USD","LU0859254822.USD","IE000F7OJYX1.SGD","PAWZ","SG9999011175.SGD","LU2097828805.USD","LLYZ","LU1691799644.USD","LU2023250504.SGD","LU0672654240.SGD","CURE","SG9999015945.SGD","LU0267386448.USD","LU2089283258.USD","MRK","IE0005OL40V9.USD","LU2097828631.EUR","IE00BFXG1179.USD","LU1244550221.USD","LU2125909593.SGD","IE00BJJMRY28.SGD","LU2491050071.SGD","LU2488822045.USD","WDNA","LU1291159041.SGD","LU0472753341.HKD","LU1037948541.HKD","LU0726765562.USD","TRUH","LU0289739343.SGD","LU0210536198.USD","LU1430594728.SGD","BK1583","BK1589","LU0395794307.EUR","LU0122379950.USD","LU1989771016.USD","REGN","BMED","LU0326950275.SGD","SG9999014567.USD","SG9999015952.SGD","LU2089284900.SGD","MHIP","GLAM","LU0096364046.USD","LU0965508806.USD","LU0942090050.USD","LU1035773651.USD","LU0289739699.SGD","LU0316494557.USD","LU1699723380.USD","BK4139","LU2896262040.SGD","MEDI","LU0097036916.USD","LU1934455863.HKD","IE0000B7K699.USD","LU0456855351.SGD","LU0310800379.SGD","LU2087621335.USD","LU1261432733.SGD","LU2129689605.HKD","LU2237443895.HKD","LU1037948897.HKD","LU2087625088.SGD","01801","IHE","LU1267930573.SGD","LU2471134796.USD","LU0889565916.HKD","LU0321505868.SGD","LU0149534421.HKD","ILDR","THNR","SG9999001176.USD","LU2756315318.SGD","LU0211331839.USD","LLY","LU0053666078.USD","IYH","LU2237443382.USD","LU2471134523.USD","LU1720051017.SGD","LU2361044949.HKD","LU0208291251.USD","LU2133065610.SGD","IE0002270589.USD","IE00BJJMRZ35.SGD","LU2213496289.HKD","LU2125909247.SGD","IE000BZT7R73.USD","LU0455707207.USD","IE000SO60NU8.SGD","LU0553294199.USD","LU0130102774.USD","LU0861579265.USD","LU0238689110.USD","LU1894683348.USD","IBBQ","LU2108987350.USD","LU0385154629.USD","IE00BN29S564.USD","IE00BVYPNW00.USD","LU2063271972.USD","LU0354030511.USD","LU0640476718.USD","LU0061475181.USD","IE00B19Z3B42.SGD","LU2265009873.SGD","LU2129689514.USD","LU2596442595.SGD","LU2328871848.SGD","LU1923622614.USD","IE00BFTCPJ56.SGD","LU0072461881.USD","LU2237438978.USD","LU0265550359.USD","LU0786609619.USD","LU1244550577.SGD","LU2552382132.HKD","FTXH","CANC","IE0004445015.USD","IE00BJT1NW94.SGD","IE00BSNM7G36.USD","LU2491050154.USD","VHT","BK4532","LU0265550946.USD","SG9999002232.USD","LU1941712264.USD","BK4568","LU2111349929.HKD","IE00BFSS7M15.SGD","LU1718418525.SGD","LU1894683264.USD","IXJ","LU2602419157.SGD","LU1280957306.USD","LU0607220059.USD","LU1670710588.SGD","LU2746668461.USD","KURE","LU0648001328.SGD","LU0545039389.USD","LU2023251221.USD","LU2362541513.USD","LU0432979614.USD","IE000MB6IJN5.SGD","IE00BN8TJ469.HKD","LU0310799852.SGD","LU2362541273.HKD","BK4588","LU2028103732.USD","LU0158827948.USD","LU0094547139.USD","LU0471298777.SGD","LU0109394709.USD","LU0098860793.USD","LU2361044865.SGD","LU0965509283.SGD","LU0133085943.USD","FHLC","LU0114720955.EUR","TMED","LU1267930490.SGD","LU1032466523.USD","LU1074936037.SGD","PJP","IE00BKPKM429.USD","LU0320765489.SGD","LU0029864427.USD","LU0738911758.USD","LU0266013472.USD","LU1236620750.USD","LU1989772923.USD","LU2237443549.SGD","BK4007","LU0079474960.USD","LU1974910355.USD","LU0795875086.SGD","LU2491049909.HKD","LU1868836591.USD","LU2264538146.SGD","IE00BDGV0183.EUR","IE00BK4W5M84.HKD","LU0106261372.USD","LU0109391861.USD","BK4585","BK1161","LU0158827781.USD","LU1629891620.HKD","LU1732799900.SGD","IE00BVYPNV92.GBP","LU2746668974.SGD","LU0912757837.SGD","LU2362540622.SGD","LU2236285917.USD","LU1804176565.USD","JDOC","LU0820561909.HKD","LU1145028129.USD","LU1066051225.USD","IE00B3T34201.USD","BBH","LU1868836914.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670731230","title":"Exchange-Traded Funds, Equity Futures Lower Pre-Bell Monday as Oil Prices Rise","url":"https://stock-news.laohu8.com/highlight/detail?id=2670731230","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670731230?lang=en_us&edition=fundamental","pubTime":"2026-09-28 21:17","pubTimestamp":1790601424,"startTime":"0","endTime":"0","summary":"The broad market exchange-traded fund SPDR S&P 500 ETF Trust (SPY) was down 0.3% and the actively traded Invesco QQQ Trust (QQQ) retreated 0.6% in Monday's premarket activity as oil prices rose amid U","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["AMPX","IYK","EETH","EQR","VDC","STLA","FAS","FAZ","RTH.AU","VHT.AU","SPY.AU","VHT","ABFL","E","KOD","XLE","IGM","XLP","XRT","VIS","SPY","BITO","NVDA","IYJ","WISE","BETH","QQQ","XLV","FTEC","XLY","IBB","STT","SLV",".DJI","RTH","IYE","IYW","XLK","XSD","XLF","UBS","SOXX","IYH","USO","ETH","GLD","UNG","XLI","FDN",".IXIC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670523034","title":"Sector Update: Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2670523034","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670523034?lang=en_us&edition=fundamental","pubTime":"2026-09-28 21:00","pubTimestamp":1790600407,"startTime":"0","endTime":"0","summary":"Healthcare stocks were flat to lower premarket Monday, with the iShares Biotechnology ETF  inactive and the State Street Health Care Select Sector SPDR ETF  down a slight 0.2%.Kodiak Sciences  stock was up more than 99% after the company said its two experimental eye drugs, Zenkuda and tabirafusp-ted, met primary endpoints in a Phase 3 study in patients with wet age-related macular degeneration.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["XLV","XBI","BK4137","BK4585","BK4581","BK4588","IBB","HCSG","LU0029874061.USD","LU0128526141.USD","KOD","LABU","BK4139","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670019231","title":"Xilio Therapeutics Names Yariv Houvras Chief Medical Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2670019231","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670019231?lang=en_us&edition=fundamental","pubTime":"2026-09-28 19:30","pubTimestamp":1790595055,"startTime":"0","endTime":"0","summary":"Xilio Therapeutics names Yariv Houvras chief medical officerXilio Therapeutics named Yariv J. Houvras chief medical officer on Sept. 28, 2026.He previously led clinical and translational development a","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nNDL8GCH5H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BMED","LU0861579265.USD","LU1934455863.HKD","LU2112291526.USD","IE00B19Z3581.USD","IE00BQXX3C00.GBP","BCDF","LU0965509283.SGD","LU1934455277.USD","LU1839511570.USD","BIB","LU0823416689.USD","SG9999015952.SGD","LU1061106388.HKD","LU2210149790.SGD","SG9999014021.USD","LU2089984988.USD","TBXU","IE00BKPKM429.USD","BK4566","LU1430594728.SGD","BK4568","BK4583","LU1571399168.USD","IE00B19Z3B42.SGD","TMED","LU1066051498.USD","IBB","LU1037948897.HKD","LU2468319806.SGD","IE00B3QW5Z07.USD","BBH","MEDI","IE00BN0W2W23.USD","LU2087621335.USD","NDAQ","IE00BN0W2V16.EUR","IE00BKVL7J92.USD","GILD","LU0859254822.USD","LU2210150020.SGD","LU1066053197.SGD","SG9999014013.SGD","IE00B3T34201.USD","LU0965509101.SGD","XLO","BK4532","IBBQ","SG9999015978.USD","LU0234570918.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670239992","title":"Kodiak Sciences Rises After Eye-Disease Drugs Meet Trial Goals","url":"https://stock-news.laohu8.com/highlight/detail?id=2670239992","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670239992?lang=en_us&edition=fundamental","pubTime":"2026-09-28 18:50","pubTimestamp":1790592624,"startTime":"0","endTime":"0","summary":"BUZZ-Kodiak Sciences rises after eye-disease drugs meet trial goals** Shares of drug developer Kodiak SciencesKOD.Orise 43.9% to $46.56 premarket** Co says its experimental drugs Zenkuda and tabirafusp-ted met the main goals of a late-stage trial in patients with wet age-related macular degeneration** Both drugs achieved vision gains at one year that were not inferior to aflibercept, the comparison treatment** Wet age-related macular degeneration causes abnormal blood vessels to leak beneath the retina and can lead to loss of central vision** About 54% of Zenkuda patients reached a six-month dosing interval, potentially reducing the number of eye injections needed** Both drugs showed safety broadly consistent with aflibercept; Kodiak plans further analyses to identify which patients may benefit most from tabirafusp-ted** Co plans to seek US approval for Zenkuda in Q4 2026, using results from five successful late-stage studies across three retinal diseases** KOD up 15.7% YTD, as of last","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nL4N45K0P4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBH","LU0320765992.SGD","LU2106854487.HKD","LU2362540622.SGD","KOD","LU0889565916.HKD","BK4585","LU0114720955.EUR","LU1974910355.USD","LU2362541513.USD","REGN","LU2023250504.SGD","LU0058720904.USD","LU0823416689.USD","LU2362541273.HKD","IBB","LU0053666078.USD","LU0109394709.USD","IBBQ","BK4505","BK4588","LU0289739699.SGD","LU0882574055.USD","LU2089984988.USD","LU0823434583.USD","LU2468319806.SGD","TBXU","LU0823434740.USD","LU1917777945.USD","LU2237438978.USD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670236928","title":"Zymeworks sees FY26 revenue $278M-$292M, consensus $304.04M","url":"https://stock-news.laohu8.com/highlight/detail?id=2670236928","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670236928?lang=en_us&edition=fundamental","pubTime":"2026-09-28 18:10","pubTimestamp":1790590220,"startTime":"0","endTime":"0","summary":"With the completion of the Theravance Biopharma acquisition and the receipt of the U.S. FDA approval of Ziihera for first-line HER2-positive advanc...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/zymeworks-sees-fy26-revenue-278m-292m-consensus-304-04m-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/zymeworks-sees-fy26-revenue-278m-292m-consensus-304-04m-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["FRTY","MRNX","BMED","GNMX","LFSC","IEIH","XLVX","RSPH","MEDI","MRNY","BK4588","BBP","GDOC","BK4585","IDNA","PINK","TBPH","BK4007","SYNB","NVIB","LABU","TECB","PSCH","IYH","TBXU","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670808280","title":"Sino Biopharmaceutical Stock Slides 1.3% in Hong Kong, Underperforms Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2670808280","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670808280?lang=en_us&edition=fundamental","pubTime":"2026-09-28 16:33","pubTimestamp":1790584380,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sino Biopharmaceutical Ltd. shed 1.3% to 5.50 Hong Kong dollars on what proved to be an all-around great trading session for the Hong Kong stock market, with the Hang Seng Index rising 0.5% to 24642.51.This was the stock's fifth consecutive day of losses.Sino Biopharmaceutical Ltd. closed 36% short of its 52-week high of HK$8.54, which the company reached Oct. 8.The stock underperformed when compared to some of its competitors, as CSPC Pharmaceutical Group Ltd. rose 0.6% and Amgen Inc. remained unchanged.Trading volume totaled 57.5 million shares, compared to the 50-day average of 82.2 million shares.Data source: Dow Jones Market Data, FactSet","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0009355771.USD","LU2468319806.SGD","IBBQ","BK4585","LU0122379950.USD","IE00BZ08YS42.EUR","BK4588","IE00B2B36J28.USD","BK1515","BK4533","BK4139","LU2089984988.USD","BK4534","LU1057294990.SGD","HK0000165453.HKD","IE00BJJMRZ35.SGD","BK4581","TBXU","BIB","01177","LU0320765992.SGD","LU0058720904.USD","IE00BZ08YR35.GBP","BBH","LU0889565916.HKD","IBB","BK1191","LU1023059063.AUD","IE00BFTCPJ56.SGD","91335","IE0002141913.USD","LU1571399168.USD","IE00B4R5TH58.HKD","LU1061106388.HKD","LU2242646821.SGD","LU0109394709.USD","LU0289739699.SGD","LU0868494617.USD","LU1983299246.USD","IE00BZ08YT58.USD","LU2242652126.USD","PJP","BK1521","BK4599","SG9999001440.SGD","BK1589","IE00BJT1NW94.SGD","AMGN","LU2112291526.USD","PBE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670402990","title":"EBR Systems advances FDA approval process for new WiSE manufacturing site","url":"https://stock-news.laohu8.com/highlight/detail?id=2670402990","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670402990?lang=en_us&edition=fundamental","pubTime":"2026-09-28 08:08","pubTimestamp":1790554084,"startTime":"0","endTime":"0","summary":"The latest announcement is out from EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh ( ($AU:EBR) ). EBR Systems, developer of the WiSE wi...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/ebr-systems-advances-fda-approval-process-for-new-wise-manufacturing-site?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/ebr-systems-advances-fda-approval-process-for-new-wise-manufacturing-site?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TBXU","EES","IDNA","NVIB","SYNB","XLVX","BBP","PSCH","RSPH","GDOC","PINK","FRTY","GNMX","BK4588","MRNY","IEIH","TECB","BMED","IYH","LABU","MEDI","IBB","BK4585","MRNX","LFSC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670471175","title":"Regeneron (REGN) Receives a Hold from Bernstein","url":"https://stock-news.laohu8.com/highlight/detail?id=2670471175","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670471175?lang=en_us&edition=fundamental","pubTime":"2026-09-26 20:55","pubTimestamp":1790427321,"startTime":"0","endTime":"0","summary":"Bernstein analyst Eve Burstein maintained a Hold rating on Regeneron yesterday and set a price target of $756.00. The company’s shares closed yeste...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/regeneron-regn-receives-a-hold-from-bernstein-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/regeneron-regn-receives-a-hold-from-bernstein-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2362541513.USD","LU2468319806.SGD","LU0823416689.USD","LU0823434583.USD","BK4585","LU1917777945.USD","LU0823434740.USD","LU2023250504.SGD","IBB","LU0320765992.SGD","LU2362540622.SGD","LU0889565916.HKD","LU0882574055.USD","LU2089984988.USD","LU0053666078.USD","LU0114720955.EUR","LU1974910355.USD","LU0058720904.USD","BK4588","TBXU","LU0109394709.USD","BBH","LU2106854487.HKD","LU0289739699.SGD","LU2362541273.HKD","REGN","LU2237438978.USD","BK4139","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670471177","title":"Analysts Are Bullish on Top Healthcare Stocks: Agilent (A), Regeneron (REGN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2670471177","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670471177?lang=en_us&edition=fundamental","pubTime":"2026-09-26 20:40","pubTimestamp":1790426416,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Agilent (A) and Regeneron (REGN) with bullish sentim...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-agilent-a-regeneron-regn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-agilent-a-regeneron-regn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0889565916.HKD","LU0109394709.USD","BK4581","LU2041044095.USD","LU2362540622.SGD","LU0823434583.USD","TBXU","LU1974910355.USD","LU2229751404.USD","BK4137","LU2468319806.SGD","XBI","LU0029874061.USD","LU0320765992.SGD","LU1917777945.USD","LU0058720904.USD","LU2092937221.SGD","LU2106854487.HKD","LU2237438978.USD","BK4121","IBBQ","LU0289739699.SGD","LU2362541273.HKD","LU0823434740.USD","LU0114720955.EUR","LU1165135440.EUR","XLV","LU2089279066.USD","LU0823416689.USD","IE00BN0W2V16.EUR","LU0347712357.USD","LU0128526141.USD","BK4139","LABU","LU2023250504.SGD","BK4585","LU2362541513.USD","IE00BN0W2T93.GBP","LU2413666699.HKD","LU2413666426.HKD","IE00BN0W2W23.USD","IBB","BBH","A","LU0053666078.USD","BK4588","HCSG","REGN","LU2089984988.USD","LU1543694498.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":3,"totalSize":200,"code":"91000000","status":"200"}]}}